KICKSTARTING HEALTHCARE CONVERSATIONS
July/August 2022 @PharmaTimes
A new chapter unfolds across the pharmaverse
Trial and era: The ignition of patient participation and clinical trial redesign
Special brew: How changes in specialised commissioning will affect industry
Same but different: The future for biosimilars in the post-COVID landscape
Download a PDF of the print edition here